Neuroscience4 days ago
FDA extends PDUFA for Biohaven’s Troriluzole new drug application
**FDA Grants Biohaven’s Troriluzole Treatment a PDUFA Extension** What’s Happening? In a twist that has left investors and patients in suspense, Biohaven Pharmaceuticals (BHVN) has received...
